Apollo Neuroscience, Inc.
AI software platform that integrates with wearable hardware to deliver physiologically-reactive vibration patterns that modulate autonomic nervous system activity to reduce stress and improve performa
- Sector
- Medtech
- Headquarters
- PITTSBURGH, PA
- Founded
- 2017
- Latest Form D
- $500K, Apr 2024
- Total capital
- $7.7M
- Federal grants
- $509K
- 3 awards · 2018–2025
- Rank in peer group#6 of 11
- Private capital raised
- $7.2M
- 5 Form D · last Apr 2024
- 30 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 6
- 23 pending · first 2021
- Rank in peer group#1 of 11
Capital timeline
Latest events
- Federal grantDefense · Phase I · Small Business Innovative Research (SBIR) Phase I Topic A254-004, Apollo Neuroscience, Inc.$250K
- Federal grantDefense · Phase I · Apollo Neuro Wearable: Reducing Chronic Fatigue And Stress To Maximize Airmen Performance$110K
- Private capital raisedForm D · SEC · 5th filing$500K
- Private capital raisedForm D · SEC · 4th filing$1.1M
- Private capital raisedForm D · SEC · 3rd filing$4.1M
- Federal grantDefense · Phase I · Non-invasive Neuroenhancement To Optimize Autonomic Nervous System Regulation And Behavioral Health With Transcutaneous Vibratory Stimulation$150K
- Private capital raisedForm D · SEC · 2nd filing$1.5M
- Private capital raisedForm D · SEC · 1st filing$100K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 11 peers
Line = medianMedtech · System
- Federal grants#6 · top 55%
- Granted patents#1 · top 9%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Alan CannistraroExecutive Officer, DirectorNamed in SEC Form D filings
- David RabinExecutive Officer, DirectorNamed in SEC Form D filings
- Gary JohnsonDirectorNamed in SEC Form D filings
- Kathryn FantauzziExecutive Officer, Director, PromoterNamed in SEC Form D filings
- Sa'ad ShahDirectorNamed in SEC Form D filings
What it has protected
USPTO · 6 granted of 29- GrantedSystems And Methods Of Transcutaneous Vibration For Sexual ArousalUSPTOUS 12,734,100
- PendingVibrating Actuator For Use With Wearable Electronic DeviceUSPTOApplication 19362167
- PendingSystem And Method Of Haptically Representing A Visual ShapeUSPTOApplication 19351120
Show all 29 patent records
- Systems And Methods Of Transcutaneous Vibration For Sexual ArousalSep 15, 2026 · US 12,734,100Granted
- Vibrating Actuator For Use With Wearable Electronic DeviceFeb 12, 2026 · Application 19362167Pending
- System And Method Of Haptically Representing A Visual ShapeJan 29, 2026 · Application 19351120Pending
- Systems And Methods Of Temperature And Visual Stimulation PatternsJul 3, 2025 · Application 19080037Pending
- Systems And Methods Of Transcutaneous VibrationMar 20, 2025 · Application 18959225Pending
- Systems And Methods Of Multi-segment Transcutaneous Vibratory OutputJan 16, 2024 · US 11,872,351Granted
- Method And System Of Sleep MaintenanceMay 4, 2023 · Application 18091044Pending
- Systems And Methods Of Facilitating Sleep State Entry With Transcutaneous VibrationDec 27, 2022 · US 11,534,571Granted
- Systems And Methods Of Transcutaneous Vibration To Synergize With Or Augment A Treatment ModalityNov 17, 2022 · Application 17873619Pending
- Systems And Methods Of Transcutaneous Vibration For Sexual ArousalNov 17, 2022 · Application 17873735Pending
- Systems And Methods Of Transcutaneous Vibration To Effect An Epigenetic OutcomeSep 15, 2022 · Application 17829462Pending
- Coordinated System Of Multiple TransducersMar 17, 2022 · Application 17533880Pending
- Systems And Methods Of Wave Generation For Transcutaneous VibrationMar 1, 2022 · US 11,260,198Granted
- Method And System Of A Pet Product With Transcutaneous Vibratory OutputJan 6, 2022 · Application 17480422Pending
- Systems And Methods Of Mitigating Negative Effects Of Therapies With Transcutaneous VibrationApr 13, 2021 · US 10,974,020Granted
- Wearable Therapeutic Stimulation Device Having A Retainer Clip For A BandFeb 16, 2021 · US D,910,862Granted
- Treatment Of Sleeplessness By Therapeutic Sonic StimulationApplication 62788564Pending
- Vibrating Actuator For Use With Wearable Electronic DevicesApplication PCTUS2024025967Pending
- System And Method Of Haptically Representing A Visual ShapeApplication PCTUS2024023334Pending
- Systems And Methods Of Temperature And Visual Stimulation PatternsApplication PCTUS2023032729Pending
- Vibrating Actuator For Use With Wearable Electronic DeviceApplication 63461469Pending
- System And Method Of Haptically Representing A Visual ShapeApplication 63457897Pending
- Systems And Methods Of Temperature And Visual Stimulation PatternsApplication 63407225Pending
- Systems And Methods Of Transcutaneous VibrationApplication PCTUS2022031045Pending
- Systems And Methods Of Transcutaneous Vibration For Sexual ArousalApplication PCTUS2021044640Pending
- Systems And Methods Of Transcutaneous Vibration For Sexual ArousalApplication 63061947Pending
- Systems And Methods Of Wave Generation For Transcutaneous VibrationApplication PCTUS2019067769Pending
- Systems And Methods Of Facilitating Neural State TransitionsApplication 62867591Pending
- Systems And Methods For Stimulation Of The Autonomic Nervous SystemApplication 62788605Pending
Related companies, and why
- NEXTILES INCSimilar federal contract value in Medtech · null in contracts
- Dermalytica Inc.Similar federal contract value in Medtech · null in contracts
- THERAFLUOR, INC.Similar federal contract value in Medtech · null in contracts
- EPIRUS, INC.Similar federal contract value in Medtech · null in contracts
- PeriCor LLCSimilar federal contract value in Medtech · null in contracts
- ACATECHOL, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .